Mundipharma Announces Launch of INVOKANA® and VOKANAMET® in Norway for the Treatment of Type 2 Diabetes as Part of Exclusive Distribution Agreement with Janssen

Mar 19 2019

FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY| PDF iconDownload PDF